Octatropine en es it fr

Octatropine Brand names, Octatropine Analogs

Octatropine Brand Names Mixture

  • No information avaliable

Octatropine Chemical_Formula

C17H32BrNO2

Octatropine RX_link

No information avaliable

Octatropine fda sheet

Octatropine msds (material safety sheet)

Octatropine Synthesis Reference

No information avaliable

Octatropine Molecular Weight

362.346 g/mol

Octatropine Melting Point

329 oC

Octatropine H2O Solubility

1600 mg/L

Octatropine State

Solid

Octatropine LogP

0.60

Octatropine Dosage Forms

Tablet (oral, 50mg)

Octatropine Indication

For use in conjunction with antacids or histamine H2-receptor antagonists in the treatment of peptic ulcer, to reduce further gastric acid secretion and delay gastric emptying.

Octatropine Pharmacology

Anisotropine methylbromide is a quaternary ammonium compound. Its use as treatment adjunct in peptic ulcer has been replaced by the use of more effective agents. Depending on the dose, anisotropine methylbromide may reduce the motility and secretory activity of the gastrointestinal system, and the tone of the ureter and urinary bladder and may have a slight relaxant action on the bile ducts and gallbladder. In general, smaller doses of anisotropine methylbromide inhibit salivary and bronchial secretions, sweating, and accommodation; cause dilatation of the pupil; and increase the heart rate. Larger doses are required to decrease motility of the gastrointestinal and urinary tracts and to inhibit gastric acid secretion.

Octatropine Absorption

Gastrointestinal absorption is poor and irregular. Total absorption after an oral dose is about 10 to 25%.

Octatropine side effects and Toxicity

No information avaliable

Octatropine Patient Information

Octatropine Organisms Affected

Humans and other mammals